基于微生物群–肠–脑轴治疗阿尔茨海默病的研究进展

Research Progress in the Treatment of Alzheimer’s Disease Based on Microbiota-Gut-Brain Axis

阿尔茨海默病(Alzheimer’s disease, AD)是老年患者中最常见的痴呆类型,目前越来越多的研究发现微生物群–肠–脑轴(microbiota-gut-brain axis, MGBA)的失调可能是导致AD发病的一个潜在机制,本文针对近年来基于MGBA治疗AD的研究进展作一阐述。

Alzheimer’s disease (AD) is the most common Alzheimer’s disease, and more and more studies have found that dysregulation of the microbiota-gut–brain axis (MGBA) may be a potential mechanism leading to the pathogenesis of AD. This article describes the recent research progress of MGBA-based treatment of AD.